Rekah Pharmaceutical (Israel) Probability of Future Stock Price Finishing Under 1499.0
| REKA Stock | ILA 1,499 110.00 7.92% |
Rekah |
Rekah Pharmaceutical Target Price Odds to finish below 1499.0
The tendency of Rekah Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move below current price in 90 days |
| 1,499 | 90 days | 1,499 | more than 94.0 |
Based on a normal probability distribution, the odds of Rekah Pharmaceutical to move below current price in 90 days from now is more than 94.0 (This Rekah Pharmaceutical Industry probability density function shows the probability of Rekah Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days trading horizon Rekah Pharmaceutical Industry has a beta of -0.24 indicating as returns on the benchmark increase, returns on holding Rekah Pharmaceutical are expected to decrease at a much lower rate. During a bear market, however, Rekah Pharmaceutical Industry is likely to outperform the market. Additionally Rekah Pharmaceutical Industry has an alpha of 0.0243, implying that it can generate a 0.0243 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Rekah Pharmaceutical Price Density |
| Price |
Predictive Modules for Rekah Pharmaceutical
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Rekah Pharmaceutical. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Rekah Pharmaceutical Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Rekah Pharmaceutical is not an exception. The market had few large corrections towards the Rekah Pharmaceutical's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Rekah Pharmaceutical Industry, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Rekah Pharmaceutical within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.02 | |
β | Beta against Dow Jones | -0.24 | |
σ | Overall volatility | 63.39 | |
Ir | Information ratio | -0.04 |
Rekah Pharmaceutical Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Rekah Pharmaceutical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Rekah Pharmaceutical can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Rekah Pharmaceutical had very high historical volatility over the last 90 days | |
| About 37.0% of the company outstanding shares are owned by corporate insiders |
Rekah Pharmaceutical Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Rekah Stock often depends not only on the future outlook of the current and potential Rekah Pharmaceutical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Rekah Pharmaceutical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 11.4 M |
Rekah Pharmaceutical Technical Analysis
Rekah Pharmaceutical's future price can be derived by breaking down and analyzing its technical indicators over time. Rekah Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Rekah Pharmaceutical Industry. In general, you should focus on analyzing Rekah Stock price patterns and their correlations with different microeconomic environments and drivers.
Rekah Pharmaceutical Predictive Forecast Models
Rekah Pharmaceutical's time-series forecasting models is one of many Rekah Pharmaceutical's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Rekah Pharmaceutical's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Rekah Pharmaceutical
Checking the ongoing alerts about Rekah Pharmaceutical for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Rekah Pharmaceutical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Rekah Pharmaceutical had very high historical volatility over the last 90 days | |
| About 37.0% of the company outstanding shares are owned by corporate insiders |
Other Information on Investing in Rekah Stock
Rekah Pharmaceutical financial ratios help investors to determine whether Rekah Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Rekah with respect to the benefits of owning Rekah Pharmaceutical security.